Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolf, S. F.
Right arrow Articles by Sypek, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolf, S. F.
Right arrow Articles by Sypek, J.

Stem Cells, Vol 12, 154-168, Copyright © 1994 by AlphaMed Press

REVIEWS

Interleukin 12: a key modulator of immune function

SF Wolf, D Sieburth and J Sypek
Genetics Institute, Cambridge, Massachusetts 02174.

Interleukin (IL)-12 was cloned on the basis of its ability to activate natural killer (NK) cells and promote the development of cytolytic T cells. With further understanding of its activities, IL-12 has emerged as an important cytokine, affecting both immune and hematologic functions. It has been shown to be necessary for the T cell independent induction of interferon (IFN)-gamma, critical for the initial suppression of bacterial and parasitic infection; for the development of a Th1 response, critical for effective host defense against intracellular pathogens; and for the activation of differentiated T lymphocytes of both CD4+ and CD8+ phenotype. IL-12 thus functions to activate and to link the innate and acquired immune responses. The therapeutic potential of these activities is suggested by studies in tumor and microbial models. IL-12 has suppressed tumor growth in all murine models examined. Antimicrobial activity has been demonstrated in bacterial, yeast, parasitic, and viral models of infection. In many of these models, activity has been linked to production of IFN-gamma and, in the parasite model, to development of a Th1 response. In addition to the therapeutic potential associated with IL-12 activity in these disease models, the understanding of its role in immune development and interaction with other cytokines, particularly antagonists, such as IL- 4 and IL-10, has clarified and extended our understanding of immune regulation and should lead to significant developments in understanding the progression of AIDS and the development of vaccine adjuvants able to direct the immune response.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
Y.-S. Lee, J.-H. Kim, K.-J. Choi, I.-K. Choi, H. Kim, S. Cho, B. C. Cho, and C.-O. Yun
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and b7-1 in an immunocompetent murine model.
Clin. Cancer Res., October 1, 2006; 12(19): 5859 - 5868.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
C. Trudeau, M. M. Cotreau, L. Stonis, K. H. Dykstra, J. L. Oestreicher, A. Strahs, A. J. Dorner, V. H. Van Cleave, W. L. Trepicchio, and U. S. Schwertschlag
A Single Administration of Recombinant Human Interleukin-12 Is Associated With Increased Expression Levels of Interferon-gamma and Signal Transducer and Activator of Transcription in Healthy Subjects
J. Clin. Pharmacol., June 1, 2005; 45(6): 649 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. M. L. Maffei, L. F. Mirels, R. A. Sobel, K. V. Clemons, and D. A. Stevens
Cytokine and Inducible Nitric Oxide Synthase mRNA Expression during Experimental Murine Cryptococcal Meningoencephalitis
Infect. Immun., April 1, 2004; 72(4): 2338 - 2349.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Kopp, P. Lenz, C. Bello-Fernandez, R. A. Kastelein, T. S. Kupper, and G. Stingl
IL-23 Production by Cosecretion of Endogenous p19 and Transgenic p40 in Keratin 14/p40 Transgenic Mice: Evidence for Enhanced Cutaneous Immunity
J. Immunol., June 1, 2003; 170(11): 5438 - 5444.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. A. Akhiani, J. Pappo, Z. Kabok, K. Schon, W. Gao, L. E. Franzen, and N. Lycke
Protection Against Helicobacter pylori Infection Following Immunization Is IL-12-Dependent and Mediated by Th1 Cells
J. Immunol., December 15, 2002; 169(12): 6977 - 6984.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. Larsson, D. Rocksen, B. Lilliehook, A. Jonsson, and A. Bucht
Dose-Dependent Activation of Lymphocytes in Endotoxin-Induced Airway Inflammation
Infect. Immun., December 1, 2000; 68(12): 6962 - 6969.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. T. Kenney, D. L. Sacks, J. P. Sypek, L. Vilela, A. A. Gam, and K. Evans-Davis
Protective Immunity Using Recombinant Human IL-12 and Alum as Adjuvants in a Primate Model of Cutaneous Leishmaniasis
J. Immunol., October 15, 1999; 163(8): 4481 - 4488.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
E. Roilides, S. Tsaparidou, I. Kadiltsoglou, T. Sein, and T. J. Walsh
Interleukin-12 Enhances Antifungal Activity of Human Mononuclear Phagocytes against Aspergillus fumigatus: Implications for a Gamma Interferon-Independent Pathway
Infect. Immun., June 1, 1999; 67(6): 3047 - 3050.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. W. Mullins, C. J. Burger, and K. D. Elgert
Paclitaxel Enhances Macrophage IL-12 Production in Tumor-Bearing Hosts Through Nitric Oxide
J. Immunol., June 1, 1999; 162(11): 6811 - 6818.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. D. Bungiro Jr., M. Goldberg, P. K. Suri, and P. M. Knopf
Interleukin-12 as an Adjuvant for an Antischistosome Vaccine Consisting of Adult Worm Antigens: Protection of Rats from Cercarial Challenge
Infect. Immun., May 1, 1999; 67(5): 2340 - 2348.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
V. Letscher-Bru, O. Villard, B. Risse, M. Zauke, J.-P. Klein, and T. T. Kien
Protective Effect of Vaccination with a Combination of Recombinant Surface Antigen 1 and Interleukin-12 against Toxoplasmosis in Mice
Infect. Immun., September 1, 1998; 66(9): 4503 - 4506.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
Y. Wang, S. P. Li, S. A. Moser, K. L. Bost, and J. E. Domer
Cytokine Involvement in Immunomodulatory Activity Affected by Candida albicans Mannan
Infect. Immun., April 1, 1998; 66(4): 1384 - 1391.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. M. Lavigne, L. R. Schopf, C. L. Chung, R. Maylor, and J. P. Sypek
The Role of Recombinant Murine IL-12 and IFN-{gamma} in the Pathogenesis of a Murine Systemic Candida albicans Infection
J. Immunol., January 1, 1998; 160(1): 284 - 292.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. P. Leonard, M. L. Sherman, G. L. Fisher, L. J. Buchanan, G. Larsen, M. B. Atkins, J. A. Sosman, J. P. Dutcher, N. J. Vogelzang, and J. L. Ryan
Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12-Associated Toxicity and Interferon-gamma Production
Blood, October 1, 1997; 90(7): 2541 - 2548.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. J. Robertson and J. Ritz
Interleukin 12: Basic Biology and Potential Applications in Cancer Treatment
Oncologist, February 1, 1996; 1(1): 88 - 97.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1994 by AlphaMed Press.